Combination Chemotherapy as Induction Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer

NCT00003037 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Lung Cancer

Interventions

DRUG: cisplatin
DRUG: docetaxel
DRUG: gemcitabine hydrochloride

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]